Page content

Our research at the Bamford centre is varied and focuses on five main areas: younger people, older people, mental health services, population studies and suicide studies.

Other Activities:

In this section

IMPACT

This three year study aims to determine what is the best way to organise the interface between services for children, young people and adults.

NISAW

An evidence base for the provision of primary care and psychological and other care services for young people.

MARQUE

MARQUE aims to increase knowledge about dementia, agitation and personhood.

QuEST

The QuEST Project aims to deliver the first standardised quality assessment tool for supported accommodation.

Autism Research Hub

To improve the health and well-being of people with autism, and their families, and support them to be more fully inclusive in civil society.

ADRC-NI

Administrative Data Research Centre – Northern Ireland (ADRC-NI).

PLACE-EE

Platforms for Ageing Community Engagement - Exchange and Enterprise.

The Institute of Public Health in Ireland

Current research is in preparation.

EQuIP

Funded by: The R&D Division of the Public Health Agency and Atlantic Philanthropies.

Understanding Suicide in Northern Ireland: A Comparison of Service Use and Needs in Urban and Rural Settings

We were commissioned by the R&D Division of the Northern Ireland Public Health Agency to address the gaps in our understanding of suicide in Northern Ireland.

GIFTS

The number of people referred to the Gender Identity Service in Northern Ireland has increased exponentially in the last five years.

Memories Cafés

Social isolation and loneliness have a negative impact on health and well-being, and people with memory loss and various forms of dementia are at particular risk of being socially isolated.

DFC

Dementia is one of the biggest health and social care challenges today. In Northern Ireland almost 20,000 people are living with this condition.

NICRN (Mental Health)

The Clinical Research Network was established to promote Northern Ireland’s involvement in large multi-centre trials and other major studies.

NAT-IC

Skin disease is one of the world’s leading causes of disease burden, having similar costs and prevalence rates compared to heart disease and diabetes.